Income Before Tax
Pre-Tax Income
Johnson & Johnson Pre-Tax Income increased by 20.6% to $5.99B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 56.1%, from $13.63B to $5.99B. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income shows an upward trend with a 14.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2007
Last reportedQ1 2026Apr 22, 2026
How to read this metric
Higher values indicate stronger overall profitability and operational efficiency before tax impacts.
Detailed definition
Measures the profitability of the company after all operating and non-operating expenses have been deducted, but before...
Peer comparison
A standard GAAP metric used universally to compare pre-tax performance across different industries.
Metric ID:
income_before_taxHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.66B | $3.85B | $1.24B | $5.20B | $5.14B | $5.17B | $3.84B | -$1.29B | $6.31B | $5.22B | $4.83B | $3.71B | $5.75B | $3.34B | $3.89B | $13.63B | $6.49B | $7.49B | $4.97B | $5.99B |
| QoQ Change | — | -42.2% | -67.8% | +320.3% | -1.1% | +0.5% | -25.8% | -133.5% | +590.0% | -17.3% | -7.5% | -23.0% | +54.8% | -41.9% | +16.4% | +250.7% | -52.4% | +15.4% | -33.7% | +20.6% |
| YoY Change | — | — | — | — | -22.8% | +34.4% | +210.2% | -124.7% | +22.6% | +0.9% | +25.7% | +388.6% | -8.8% | -36.0% | -19.5% | +267.0% | +12.9% | +124.5% | +27.8% | -56.1% |
Range-$1.29B – $13.63B
CAGR-2.2%
Avg YoY Growth+52.9%
Median YoY Growth+17.8%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Innovative Medicine | $5.46B | $4.48B | $4.01B | $5.21B | $5.55B | $6.45B | $5.06B | $5.32B |
| MEDTECH | $1.09B | $1.06B | $72.00M | $1.42B | $1.20B | $1.29B | $201.00M | $1.24B |
| Total | $5.75B | $3.34B | $3.89B | $13.63B | $6.49B | $7.49B | $4.97B | $5.99B |
Pre-Tax Income at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's pre-tax income?
- Johnson & Johnson (JNJ) reported pre-tax income of $5.99B in Q1 2026.
- How has Johnson & Johnson's pre-tax income changed year-over-year?
- Johnson & Johnson's pre-tax income decreased by 56.1% year-over-year, from $13.63B to $5.99B.
- What is the long-term trend for Johnson & Johnson's pre-tax income?
- Over 4 years (2021 to 2025), Johnson & Johnson's pre-tax income has grown at a 14.2% compound annual growth rate (CAGR), from $19.18B to $32.58B.
- What does pre-tax income mean?
- Total profit earned before accounting for income tax obligations.